Abstract:Objectives: Epidermal Growth Factor Receptor variant III (EGFRvIII) has been believed to be an attractive tumor-specific candidate for molecular targeting therapy. However, there is little literature dealing with this variant of EGFR expressed in laryngeal carcinomas. In the present study, we try to evaluate the expression of EGFRvIII, a, well as EGFR, in laryngeal carcinoma tissues and its correlation with clinicopathological features.Methods: Real-time polymerase chain reaction (real-time PCR) with TaqMan probes was applied to detect the expression for EGFR and EGFRvIII mRNA in the 39 pairs of samples of laryngeal carcinoma tissues and microscopically normal laryngeal mucosal tissues adjacent to the tumor. 2(-Delta Delta CT) method was used to obtain the relative quantity of target mRNA expression. The correlation between EGFRvIII expression and its clinicopathological features was analyzed by Pearson's chi-squared test.Results: Among the 39 pairs of samples of laryngeal carcinoma tissues and microscopically normal laryngeal mucosal tissues adjacent to the turner, the level of EGFR mRNA of the former (0.030 +/- 0.076) was higher than that of the latter (0.011 +/- 0.046) (P < 0.01). EGFRvIII mRNA was detected only in six samples of laryngeal carcinoma tissues. While, as control, in 39 samples of microscopically normal laryngeal mucosal tissues, EGFRvIII mRNA was hardly detected. As analyzing the correlation between expression of EGFRvIII and EGFR, we found the positive rate of EGFRvIII expression was higher in samples with relative EGFR mRNA value >= 0.025 than those of EGFR mRNA < 0.025. The difference between them was statistically significant (P < 0.05).Conclusions: Expression of EGFRvIII in laryngeal carcinoma was confirmed in this study. It is tumor-specific and tends to be more frequent in EGFR-over expressing tumor tissues and poorly differentiated ones, which may in part contribute to the malignant phenotype. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

Expression of Interleukin-18 in Laryngeal Squamous Cell Carcinoma

Clinical Significance and Detection of IL-18 in the Chronic Patients with HBV Infection

Th17 Expression And Il-17 Levels In Laryngeal Squamous Cell Carcinoma Patients

[Expression of Perlecan in Laryngeal Carcinoma Cell and Its Significance].

Expression of Interleukin-18 in Oral Squamous Cell Carcinoma

IL-35 Expression is Increased in Laryngeal Squamous Cell Carcinoma and in the Peripheral Blood of Patients.

High Serum CCL18 Predicts a Poor Prognosis in Patients with Laryngeal Squamous Cell Carcinoma

Expression of Caveolin-1 and Its Correlation with HPV Infection in Laryngeal Squamous Cell Carcinoma

Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer

The clinical significance of Interleukin 24 and its potential molecular mechanism in laryngeal squamous cell carcinoma.

SERUM INTERLEUKIN-18 LEVEL AS A PROGNOSTIC MARKER IN PATIENTS WITH COLORECTAL CARCINOMA

Serum interleukin-18 as a prognostic factor for hepatocellular carcinoma patients

Serum Levels and Clinical Significance of IL-18 and IL-1βin Patients with Gastric Cancer

Interleukin-18 expression in oral squamous cell carcinoma: its role in tumor cell migration and invasion, and growth of tumor cell xenografts.

Expression of HPV16、18E6 Gene in Laryngeal Carcinoma

Expression of Epidermal Growth Factor Receptor Variant Iii in Laryngeal Carcinoma Tissues

Role of T Helper 17 Cytokines in the Tumour Immune Inflammation Response of Patients with Laryngeal Squamous Cell Carcinoma.

Association of Interleukin-10 Promoter Polymorphisms and Corresponding Plasma Levels with Susceptibility to Laryngeal Squamous Cell Carcinoma

[Expression of Endothelin-1 in Laryngeal Carcinoma].

Two Potential Biomarkers for the Diagnosis and Prognosis of Laryngeal Carcinoma: CCL20 and IL-17A

Expression Level and Possible Role of Interleukin 18 in Metastatic Model of Lung Giant Cell Carcinoma